Earnings calls

Vijaya Diagnost. concall ledger

Every earnings call for VIJAYA — management tone, guidance, KPIs and promise tracking, quarter by quarter.

VIJAYA · 5 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 08 May 2026Call held 08 May 2026

VIJAYA Q4 FY26 Earnings Call Transcript & Analysis

FY26 Consolidated Revenue₹814 cr+20% YoYFY26 EBITDA₹337 cr+23% YoYFY26 EBITDA Margin41.4%FY26 PAT₹173 crFY26 PAT Margin21.2%

FY26 Consolidated Revenue ₹814 cr (+20% YoY); FY26 EBITDA ₹337 cr (+23% YoY); FY26 EBITDA Margin 41.4%. Q4 FY26 Consolidated Revenue of ₹219 crores, up 26.6% YoY.

Read full transcript & analysis

Q3 FY26Published 13 Feb 2026Call held 13 Feb 2026

VIJAYA Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹205 cr+21% YoYEBITDA₹86 cr+28% YoYEBITDA Margin41.9%PAT₹43 cr+22% YoYPAT Margin21%

Revenue (Q3 FY26) ₹205 cr (+21% YoY); EBITDA (Q3 FY26) ₹86 cr (+28% YoY); EBITDA Margin (Q3 FY26) 41.9%. Highest ever quarterly revenue of ~INR 205 crores, up 21.4% YoY.

Read full transcript & analysis

Q2 FY26Published 04 Nov 2025Call held 04 Nov 2025

VIJAYA Q2 FY26 Earnings Call Transcript & Analysis

Q2 FY26 Revenue₹202 cr+10% YoYQ2 FY26 EBITDA Margin40.6%Q2 FY26 PAT Margin21.5%Q2 FY26 Test Volume Growth0.083 yoyH1 FY26 Revenue₹390 cr+15% YoY

Q2 FY26 Revenue ₹202 cr (+10% YoY); Q2 FY26 EBITDA Margin 40.6%; Q2 FY26 PAT Margin 21.5%. Q2 FY26 Consolidated revenue at Rs.202 crores, reflecting 10.2% YoY growth.

Read full transcript & analysis

Q1 FY26Published 28 Jul 2025Call held 28 Jul 2025

VIJAYA Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹188 cr+20% YoYEBITDA Margin39.1%PAT Margin20.4%

Revenue ₹188 cr (+20% YoY); EBITDA Margin 39.1%; PAT Margin 20.4%. Revenue of ₹188 crores, up 20.4% YoY.

Read full transcript & analysis

Q4 FY25Published 12 May 2025Call held 12 May 2025

VIJAYA Q4 FY25 Earnings Call Transcript & Analysis

FY25 Consolidated Revenue₹681 cr+24% YoYFY25 EBITDA₹273 cr+24% YoYFY25 EBITDA Margin40.1%FY25 PAT₹143 crFY25 PAT Margin21%

FY25 Consolidated Revenue ₹681 cr (+24% YoY); FY25 EBITDA ₹273 cr (+24% YoY); FY25 EBITDA Margin 40.1%. Q4 FY25 Consolidated Revenue at INR 173 crores, up 12% YoY (13% organic).

Read full transcript & analysis